Nuvation Bio (NUVB) Gains (Losses) on Sale of Assets & Investments (2020 - 2026)
Nuvation Bio (NUVB) reported Non Operating Investment Income of $9,000 for Q2 2026, compared with -$34,000 a year earlier and up 12.5% from the prior quarter.
Powered by 
Analysis
Nuvation Bio (NUVB) Gains (Losses) on Sale of Assets & Investments (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Nuvation Bio's Non Operating Investment Income came in at $18,000; for FY2025, it came in at -$33,000.
- By year, Non Operating Investment Income came in at -$12,000 in FY2024 and -$139,000 in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Non Operating Investment Income since Q4 2023.
- Per Business Quant data, the three quarters before Q2 2026 came in at $8,000 (Q1 2026), -$3,000 (Q4 2025) and $4,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Nuvation Bio | 1.46 Bn | -931.95 Mn | 42.84 Mn | -13,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -13,000.00 |
| Jun 30, 2026 | 9,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | -3,000.00 |
| Sep 30, 2025 | 4,000.00 |
| Jun 30, 2025 | -34,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Sep 30, 2023 | 12,000.00 |
| Jun 30, 2023 | -99,000.00 |
| Mar 31, 2023 | 2.59 Mn |
| Dec 31, 2022 | -129,000.00 |
| Sep 30, 2022 | -191,000.00 |
| Jun 30, 2022 | -694,000.00 |
| Mar 31, 2022 | -5.03 Mn |
| Dec 31, 2021 | -2.80 Mn |
API Access
Nuvation Bio Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NUVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "NUVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NUVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();